Microbot Medical (MBOT) EBITDA Margin (2010 - 2026)

Microbot Medical (MBOT) reported EBITDA Margin of 4114.29% for Q1 2026, down 193.64% quarter-over-quarter from 1401.14% in Q1 2017.

Microbot Medical (MBOT) EBITDA Margin (2010 - 2026) Analysis & Trends

Microbot Medical has reported EBITDA Margin for 9 years, with the latest figure at 4114.29% in Q1 2026.

For the quarter ending Q1 2026, EBITDA Margin changed N/A year-over-year to 4114.29%; the trailing twelve-month figure through Mar 2026 stood at 4537.73% (changed N/A YoY), and the FY2017 full-year result was 4239.66%, up 876314.0% from the prior year.
EBITDA Margin for Q1 2026 stood at 4114.29%, down from 1401.14% in the prior quarter.
The five-year high for EBITDA Margin was 4114.29% in Q1 2026, with the low at 4114.29% in Q1 2026.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBITDA Margin (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn	28.86%
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn	1.97%
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn	1.63%
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn	34.92%
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn	20.96%
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn	4.04%
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn	-9.90%
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn	13.65%
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn	2.44%
10	Microbot Medical	122.56 Mn	52.91 Mn	2,000.00	-4,114.29%

Historic Data

Download Data

Date	Value
Mar 31, 2026	-4,114.29%
Mar 31, 2017	-1,401.14%
Dec 31, 2016	-6,192.72%
Sep 30, 2016	-1,968.74%
Jun 30, 2016	402.58%
Mar 31, 2016	1,230.36%
Dec 31, 2015	100,468.63%
Sep 30, 2015	-26,972.54%
Jun 30, 2015	-30,774.23%
Mar 31, 2015	-42,674.62%
Dec 31, 2014	-1,101.83%
Sep 30, 2014	-7,779.98%
Jun 30, 2014	-34,606.54%
Mar 31, 2014	-28,508.76%
Dec 31, 2013	-19,907.16%
Sep 30, 2013	-17,515.96%
Jun 30, 2013	-18,852.32%
Mar 31, 2013	-11,173.48%
Dec 31, 2012	-2,917.39%
Sep 30, 2012	-1,923.19%